Ad

KNE – Kane Biotech Inc

Compliant

★★☆☆☆

Kane Biotech Inc is Shariah compliant. The company’s financials pass two standards and fail in three.

$8,516,566

Market cap

82.81%

Revenue Growth

-

Analysts' Rating

Ad
N/A

1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Total Analysts: 0

Company Profile

Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies and products, which includes DispersinB, Aledex, bluestem, bluestem, Coactiv+, Coactiv+, goldstem, silkstem, DermaKB and DermaKB Biofilm. Its Wound Care & Surgical division is focused on the product development of DispersinB for applications in chronic wound care. Its bluestem product line includes water additives, chews, spray and dental wipes. The Company’s other products in the early development stage includes Coactiv+, antimicrobial hydrogel for use in chronic wounds, Coactiv+, antimicrobial surgical hydrogel for use in surgical and acute wounds and DispersinB Gel for prosthetic joint infection. It also provides Scalp Detoxifier, Shampoo and Shampoo Bars. Its primary markets for its technologies are animal health and human health.

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan

Ad

Responses